Plus   Neg

Integra Lifesciences Holdings Corp Q2 adjusted earnings Beat Estimates

Integra Lifesciences Holdings Corp (IART) announced a profit for its second quarter that rose from last year.

The company's bottom line came in at $29.74 million, or $0.34 per share. This compares with $11.38 million, or $0.14 per share, in last year's second quarter.

Excluding items, Integra Lifesciences Holdings Corp reported adjusted earnings of $63.35 million or $0.73 per share for the period.

Analysts had expected the company to earn $0.66 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 4.8% to $383.65 million from $366.19 million last year.

Integra Lifesciences Holdings Corp earnings at a glance:

-Earnings (Q2): $63.35 Mln. vs. $50.51 Mln. last year.
-EPS (Q2): $0.73 vs. $0.60 last year.
-Analysts Estimate: $0.66
-Revenue (Q2): $383.65 Mln vs. $366.19 Mln last year.

Full year EPS guidance: $2.70 - $2.75
Full year revenue guidance: $1.515 - $1.525 Bln

For comments and feedback contact: editorial@rttnews.com

Follow RTT